Progesterone as a potential neuroprotective treatment in the retina

References

• Prevent blindness America. The economic impact of vision problems: the toll of major adult eye disorders, visual impairment, and blindness on the US. Economy. Place. 2007. Available from: http://costofvision.preventblindness.org/downloads [Last accessed 27 August 2013]
   Google Scholar
• CDC. The state of vision, aging, and public health in America. Place. 2011. Available from: www.cdc.gov/visionhealth/pdf/vision_brief.pdf [Last accessed 27 August 2013]
   Google Scholar
• Dunkin JM, Crum AV, Swanger RS, Bokhari SA. Globe trauma. Semin Ultrasound CT MR 2011;32:51-6
   PubMed Web of Science ®Google Scholar
• Morley MG, Nguyen JK, Heier JS, et al. Blast eye injuries: a review for first responders. Disaster Med Public Health Prep 2010;4:154-60
   PubMed Web of Science ®Google Scholar
• Parver LM. Eye trauma. The neglected disorder. Arch Ophthalmol 1986;104:1452-3
   PubMedGoogle Scholar
• Benavente O, Eliasziw M, Streifler JY, et al. Prognosis after transient monocular blindness associated with carotid-artery stenosis. N Engl J Med 2001;345:1084-90
   PubMed Web of Science ®Google Scholar
• Mead GE, Lewis SC, Wardlaw JM, Dennis MS. Comparison of risk factors in patients with transient and prolonged eye and brain ischemic syndromes. Stroke 2002;33:2383-90
   PubMed Web of Science ®Google Scholar
• Falke P, Abela BM Jr, Krakau CE, et al. High frequency of asymptomatic visual field defects in subjects with transient ischaemic attacks or minor strokes. J Intern Med 1991;229:521-5
   PubMed Web of Science ®Google Scholar
• Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol 1999;128:733-8
   PubMed Web of Science ®Google Scholar
• Hayreh SS. Anterior ischaemic optic neuropathy. I. Terminology and pathogenesis. Br J Ophthalmol 1974;58:955-63
   PubMed Web of Science ®Google Scholar
• Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet 2006;368:1795-809
   PubMed Web of Science ®Google Scholar
• Varma R, Lee PP, Goldberg I, Kotak S. An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol 2011;152:515-22
   PubMed Web of Science ®Google Scholar
• Schwartz M. Lessons for glaucoma from other neurodegenerative diseases: can one treatment suit them all? J Glaucoma 2005;14:321-3
   PubMed Web of Science ®Google Scholar
• Pang IH, Clark AF. Rodent models for glaucoma retinopathy and optic neuropathy. J Glaucoma 2007;16:483-505
   PubMed Web of Science ®Google Scholar
• Parke DW 3rd, Flynn HW Jr, Fisher YL. Management of intraocular foreign bodies: a clinical flight plan. Can J Ophthalmol 2013;48:8-12
   PubMed Web of Science ®Google Scholar
• Scott R. The injured eye. Philos Trans R Soc Lond B Biol Sci 2011;366:251-60
   PubMed Web of Science ®Google Scholar
• McClenaghan FC, Ezra DG, Holmes SB. Mechanisms and management of vision loss following orbital and facial trauma. Curr Opin Ophthalmol 2011;22:426-31
   PubMed Web of Science ®Google Scholar
• Hayreh SS. Vascular disorders in neuro-ophthalmology. Curr Opin Neurol 2011;24:6-11
   PubMed Web of Science ®Google Scholar
• Hayreh SS. Ischemic optic neuropathy. Prog Retin Eye Res 2009;28:34-62
   PubMed Web of Science ®Google Scholar
• London NJ, Brown G. Update and review of central retinal vein occlusion. Curr Opin Ophthalmol 2011;22:159-65
   PubMed Web of Science ®Google Scholar
• Ofri R, Narfstrom K. Light at the end of the tunnel? Advances in the understanding and treatment of glaucoma and inherited retinal degeneration. Vet J 2007;174:10-22
   PubMed Web of Science ®Google Scholar
• Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 2001;28:92-5
   PubMed Web of Science ®Google Scholar
• Dejneka NS, Surace EM, Aleman TS, et al. In utero gene therapy rescues vision in a murine model of congenital blindness. Mol Ther 2004;9:182-8
   PubMed Web of Science ®Google Scholar
• Jacobson SG, Aleman TS, Cideciyan AV, et al. Identifying photoreceptors in blind eyes caused by rpe65 mutations: prerequisite for human gene therapy success. Proc Natl Acad Sci USA 2005;102:6177-82
   PubMed Web of Science ®Google Scholar
• McKinnon SJ, Goldberg LD, Peeples P, et al. Current management of glaucoma and the need for complete therapy. Am J Manag Care 2008;14:S20-7
   PubMedGoogle Scholar
• Danesh-Meyer HV. Neuroprotection in glaucoma: recent and future directions. Curr Opin Ophthalmol 2011;22:78-86
   PubMed Web of Science ®Google Scholar
• Hartwick AT. Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy. Optom Vis Sci 2001;78:85-94
   PubMed Web of Science ®Google Scholar
• Sayeed I, Stein DG. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog Brain Res 2009;175:219-37
   PubMed Web of Science ®Google Scholar
• Stein DG, Wright DW. Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin Investig Drugs 2010;19:847-57
   PubMed Web of Science ®Google Scholar
• Deutsch ER, Espinoza TR, Atif F, et al. Progesterone’s role in neuroprotection, a review of the evidence. Brain Res 2013;1530:82-105
   PubMed Web of Science ®Google Scholar
• Tsutsui K, Ukena K, Usui M, et al. Novel brain function: Biosynthesis and actions of neurosteroids in neurons. Neurosci Res 2000;36:261-73
   PubMed Web of Science ®Google Scholar
• Lopez V, Wagner CK. Progestin receptor is transiently expressed perinatally in neurons of the rat isocortex. J Comp Neurol 2009;512:124-39
   PubMed Web of Science ®Google Scholar
• Attella MJ, Nattinville A, Stein DG. Hormonal state affects recovery from frontal cortex lesions in adult female rats. Behav Neural Biol 1987;48:352-67
   PubMedGoogle Scholar
• Roof RL, Duvdevani R, Braswell L, Stein DG. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol 1994;129:64-9
   PubMed Web of Science ®Google Scholar
• Roof RL, Duvdevani R, Stein DG. Progesterone treatment attenuates brain edema following contusion injury in male and female rats. Restor Neurol Neurosci 1992;4:425-7
   PubMed Web of Science ®Google Scholar
• Progesterone for the treatment of traumatic brain injury (ProTECT III). Available from: http://clinicaltrials.gov/show/NCT00822900
   Google Scholar
• Wright DW, Kellermann AL, Hertzberg VS, et al. Protect: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 2007;49:391-402. 402.e391-392
   PubMed Web of Science ®Google Scholar
• Xiao G, Wei J, Yan W, et al. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 2008;12:R61
   PubMed Web of Science ®Google Scholar
• Gonzalez SL, Labombarda F, Gonzalez Deniselle MC, et al. Progesterone up-regulates neuronal brain-derived neurotrophic factor expression in the injured spinal cord. Neuroscience 2004;125:605-14
   PubMed Web of Science ®Google Scholar
• Chan JR, Phillips LJ 2nd, Glaser M. Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. Proc Natl Acad Sci USA 1998;95:10459-64
   PubMed Web of Science ®Google Scholar
• Ibanez C, Shields SA, El-Etr M, et al. Systemic progesterone administration results in a partial reversal of the age-associated decline in CNS remyelination following toxin-induced demyelination in male rats. Neuropathol Appl Neurobiol 2004;30:80-9
   PubMed Web of Science ®Google Scholar
• Gonzalez Deniselle MC, Garay L, Gonzalez S, et al. Progesterone restores retrograde labeling of cervical motoneurons in Wobbler mouse motoneuron disease. Exp Neurol 2005;195:518-23
   PubMed Web of Science ®Google Scholar
• Guo Q, Sayeed I, Baronne LM, et al. Progesterone administration modulates aqp4 expression and edema after traumatic brain injury in male rats. Exp Neurol 2006;198:469-78
   PubMed Web of Science ®Google Scholar
• Puia G, Belelli D. Neurosteroids on our minds. Trends Pharmacol Sci 2001;22:266-7
   PubMedGoogle Scholar
• Reddy DS, O’Malley BW, Rogawski MA. Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology 2005;48:14-24
   PubMed Web of Science ®Google Scholar
• Monnet FP, Mahe V, Robel P, Baulieu EE. Neurosteroids, via sigma receptors, modulate the [3h]norepinephrine release evoked by n-methyl-d-aspartate in the rat hippocampus. Proc Natl Acad Sci USA 1995;92:3774-8
   PubMed Web of Science ®Google Scholar
• Djebaili M, Guo Q, Pettus EH, et al. The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J Neurotrauma 2005;22:106-18
   PubMed Web of Science ®Google Scholar
• Yao XL, Liu J, Lee E, et al. Progesterone differentially regulates pro- and anti-apoptotic gene expression in cerebral cortex following traumatic brain injury in rats. J Neurotrauma 2005;22:656-68
   PubMed Web of Science ®Google Scholar
• Drew PD, Chavis JA. Female sex steroids: effects upon microglial cell activation. J Neuroimmunol 2000;111:77-85
   PubMed Web of Science ®Google Scholar
• Miller L, Hunt JS. Regulation of tnf-alpha production in activated mouse macrophages by progesterone. J Immunol 1998;160:5098-104
   PubMed Web of Science ®Google Scholar
• Cutler SM, Cekic M, Miller DM, et al. Progesterone improves acute recovery after traumatic brain injury in the aged rat. J Neurotrauma 2007;24:1475-86
   PubMed Web of Science ®Google Scholar
• Si D, Yang P, Jiang R, et al. Improved cognitive outcome after progesterone administration is associated with protecting hippocampal neurons from secondary damage studied in vitro and in vivo. Behav Brain Res 2014;264:135-42
   PubMed Web of Science ®Google Scholar
• Doonan F, O’Driscoll C, Kenna P, Cotter TG. Enhancing survival of photoreceptor cells in vivo using the synthetic progestin norgestrel. J Neurochem 2011;118:915-27
   PubMed Web of Science ®Google Scholar
• Neumann F, Wurm A, Linnertz R, et al. Sex steroids inhibit osmotic swelling of retinal glial cells. Neurochem Res 2010;35:522-30
   PubMed Web of Science ®Google Scholar
• Lu N, Li C, Cheng Y, Du AL. Protective effects of progesterone against high intraocular pressure-induced retinal ischemia-reperfusion in rats. Nan Fang Yi Ke Da Xue Xue Bao 2008;28:2026-9
   PubMedGoogle Scholar
• Sanchez-vallejo V, Benloch-Navarro S, Alvarez-Nolting R, et al. Progesterone administration decreases glutamate concentration in the retina of an animal model of retinitis pigmentosa. The Association for Research in Vision and Ophthalmology Annual Meeting, USA, 2013. Abstract No. A0133
   Google Scholar
• Cubilla MA, Bachor TP, Bermudez V, et al. Progesterone protects photoreceptors from light-induced damage. The Association for Research in Vision and Ophthalmology Annual Meeting, USA, 2012. Abstract No. D943
   Google Scholar
• Araiz JJ, Sanchez-vallejo V, Flores-Bellver M, et al. Progesterone administration effects on an animal model of retinitis pigmentosa. The Association for Research in Vision and Ophthalmology Annual Meeting, USA, 2012. Abstract No. A303
   Google Scholar
• Nakazawa T, Takahashi H, Shimura M. Estrogen has a neuroprotective effect on axotomized RGCs through ERK signal transduction pathway. Brain Res 2006;1093:141-9
   PubMed Web of Science ®Google Scholar
• Kaldi I, Berta A. Progesterone administration fails to protect albino male rats against photostress-induced retinal degeneration. Eur J Ophthalmol 2004;14:306-14
   PubMed Web of Science ®Google Scholar
• O’Steen WK. Ovarian steroid effects on light-induced retinal photoreceptor damage. Exp Eye Res 1977;25:361-9
   PubMed Web of Science ®Google Scholar
• Yu X, Rajala RV, McGinnis JF, et al. Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17 beta-estradiol-mediated neuroprotection. J Biol Chem 2004;279:13086-94
   PubMed Web of Science ®Google Scholar
• Li YC, Hayes S, Young AP. Steroid hormone receptors activate transcription in glial cells of intact retina but not in primary cultures of retinal glial cells. J Mol Neurosci 1997;8:145-58
   PubMed Web of Science ®Google Scholar
• Murphy SJ, Traystman RJ, Hurn PD, Duckles SP. Progesterone exacerbates striatal stroke injury in progesterone-deficient female animals. Stroke 2000;31:1173-8
   PubMed Web of Science ®Google Scholar
• Ishrat T, Sayeed I, Atif F, et al. Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase b signaling pathway. Neuroscience 2012;210:442-50
   PubMed Web of Science ®Google Scholar
• Ishrat T, Sayeed I, Atif F, Stein DG. Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats. Brain Res 2009;1257:94-101
   PubMed Web of Science ®Google Scholar
• Sayeed I, Wali B, Stein DG. Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restor Neurol Neurosci 2007;25:151-9
   PubMed Web of Science ®Google Scholar
• Won S, Lee JH, Wali B, et al. Progesterone attenuates hemorrhagic transformation after delayed tpa treatment in an experimental model of stroke in rats: Involvement of the vegf-mmp pathway. J Cereb Blood Flow Metab 2014;34(1):72-80
   PubMed Web of Science ®Google Scholar
• Yousuf S, Atif F, Sayeed I, et al. Post-stroke infections exacerbate ischemic brain injury in middle-aged rats: immunomodulation and neuroprotection by progesterone. Neuroscience 2013;239:92-102
   PubMed Web of Science ®Google Scholar
• Yousuf S, Sayeed I, Atif F, et al. Delayed progesterone treatment reduces brain infarction and improves functional outcomes after ischemic stroke: a time-window study in middle-aged rats. J Cereb Blood Flow Metab 2014;34(2):297-306
   PubMed Web of Science ®Google Scholar
• Cutler SM, Pettus EH, Hoffman SW, Stein DG. Tapered progesterone withdrawal enhances behavioral and molecular recovery after traumatic brain injury. Exp Neurol 2005;195:423-9
   PubMed Web of Science ®Google Scholar
• Cutler SM, Vanlandingham JW, Stein DG. Tapered progesterone withdrawal promotes long-term recovery following brain trauma. Exp Neurol 2006;200:378-85
   PubMed Web of Science ®Google Scholar
• Lanthier A, Patwardhan VV. Effect of heterosexual olfactory and visual stimulation on 5-en-3 beta-hydroxysteroids and progesterone in the male rat brain. J Steroid Biochem 1987;28:697-701
   PubMedGoogle Scholar
• Lanthier A, Patwardhan VV. Sex steroids and 5-en-3 beta-hydroxysteroids in specific regions of the human brain and cranial nerves. J Steroid Biochem 1986;25:445-9
   PubMedGoogle Scholar
• Chong AP, Aw SE. Postmortem endocrine levels in the vitreous humor. Ann Acad Med Singapore 1986;15:606-9
   PubMedGoogle Scholar
• Wickham LA, Gao J, Toda I, et al. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand 2000;78:146-53
   PubMedGoogle Scholar
• Koulen P, Madry C, Duncan RS, et al. Progesterone potentiates IP(3)-mediated calcium signaling through Akt/PKB. Cell Physiol Biochem 2008;21:161-72
   PubMedGoogle Scholar
• Swiatek-De Lange M, Stampfl A, Hauck SM, et al. Membrane-initiated effects of progesterone on calcium dependent signaling and activation of VEGF gene expression in retinal glial cells. Glia 2007;55:1061-73
   PubMed Web of Science ®Google Scholar
• Svec F, Yeakley J, Harrison RW 3rd. Progesterone enhances glucocorticoid dissociation from the att-20 cell glucocorticoid receptor. Endocrinology 1980;107:566-72
   PubMed Web of Science ®Google Scholar
• Svec F, Teubner V, Tate D. Location of the second steroid-binding site on the glucocorticoid receptor. Endocrinology 1989;125:3103-8
   PubMed Web of Science ®Google Scholar
• Valera S, Ballivet M, Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 1992;89:9949-53
   PubMed Web of Science ®Google Scholar
• Maurice T, Su TP, Privat A. Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate b25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience 1998;83:413-28
   PubMed Web of Science ®Google Scholar
• Su TP, Hayashi T. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr Med Chem 2003;10:2073-80
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Moore JT, Wade L, et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 1998;92:73-82
   PubMed Web of Science ®Google Scholar
• Langmade SJ, Gale SE, Frolov A, et al. Pregnane x receptor (pxr) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease. Proc Natl Acad Sci USA 2006;103:13807-12
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lu M, Sun X, et al. Expression and activity of p-glycoprotein elevated by dexamethasone in cultured retinal pigment epithelium involve glucocorticoid receptor and pregnane x receptor. Invest Ophthalmol Vis Sci 2012;53:3508-15
   PubMed Web of Science ®Google Scholar
• Cascio C, Russo D, Drago G, et al. 17beta-estradiol synthesis in the adult male rat retina. Exp Eye Res 2007;85:166-72
   PubMed Web of Science ®Google Scholar
• Lanthier A, Patwardhan VV. In vitro steroid metabolism by rat retina. Brain Res 1988;463:403-6
   PubMed Web of Science ®Google Scholar
• Coca-Prados M, Ghosh S, Wang Y, et al. Sex steroid hormone metabolism takes place in human ocular cells. J Steroid Biochem Mol Biol 2003;86:207-16
   PubMed Web of Science ®Google Scholar
• Sakamoto H, Ukena K, Tsutsui K. Activity and localization of 3beta-hydroxysteroid dehydrogenase/delta5-delta4-isomerase in the zebrafish central nervous system. J Comp Neurol 2001;439:291-305
   PubMed Web of Science ®Google Scholar
• Guarneri P, Guarneri R, Cascio C, et al. Neurosteroidogenesis in rat retinas. J Neurochem 1994;63:86-96
   PubMed Web of Science ®Google Scholar
• Muniz A, Betts BS, Trevino AR, et al. Evidence for two retinoid cycles in the cone-dominated chicken eye. Biochemistry 2009;48:6854-63
   PubMed Web of Science ®Google Scholar
• Hernandez-Falcon J, Schneider-Ehrenberg O, De la OM, et al. Steroids modulate the excitability of crayfish (procambarus digueti) photoreceptors: long- and short-term actions. Gen Comp Endocrinol 1997;105:255-69
   PubMed Web of Science ®Google Scholar
• Lindsey JD, Weinreb RN. Survival and differentiation of purified retinal ganglion cells in a chemically defined microenvironment. Invest Ophthalmol Vis Sci 1994;35:3640-8
   PubMed Web of Science ®Google Scholar
• Lippman ME, Wiggert BO, Chader GJ, Thompson EB. Glucocorticoid receptors. Characteristics, specificity, and ontogenesis in embryonic chick neural retina. J Biol Chem 1974;249:5916-17
   PubMed Web of Science ®Google Scholar
• Bahring R, Standhardt H, Martelli EA, Grantyn R. Gaba-activated chloride currents of postnatal mouse retinal ganglion cells are blocked by acetylcholine and acetylcarnitine: how specific are ion channels in immature neurons? Eur J Neurosci 1994;6:1089-99
   PubMed Web of Science ®Google Scholar
• Obal A. Progesterone therapy in glaucoma. Klin Monbl Augenheilkd Augenarztl Fortbild 1950;117:201-3
   PubMedGoogle Scholar
• Posthumus RG. The use and the possibilities of progesterone in the treatment of glaucoma. Ophthalmologica 1952;124:17-25
   PubMed Web of Science ®Google Scholar
• Suzuki T, Schirra F, Richards SM, et al. Estrogen’s and progesterone’s impact on gene expression in the mouse lacrimal gland. Invest Ophthalmol Vis Sci 2006;47:158-68
   PubMed Web of Science ®Google Scholar
• Sullivan DA, Jensen RV, Suzuki T, Richards SM. Do sex steroids exert sex-specific and/or opposite effects on gene expression in lacrimal and meibomian glands? Mol Vis 2009;15:1553-72
   PubMed Web of Science ®Google Scholar
• Lambert BW. The effects of progestins and estrogens on the permeability of the lens. Arch Ophthalmol 1968;80:230-4
   PubMedGoogle Scholar
• Panchami Pai SR, Shenoy JP, et al. Postmenopausal intraocular pressure changes in south Indian females. J Clin Diagn Res 2013;7:1322-4
   PubMedGoogle Scholar
• Ziai N, Ory SJ, Khan AR, Brubaker RF. Beta-human chorionic gonadotropin, progesterone, and aqueous dynamics during pregnancy. Arch Ophthalmol 1994;112:801-6
   PubMedGoogle Scholar
• Yucel I, Akar ME, Dora B, et al. Effect of the menstrual cycle on standard achromatic and blue-on-yellow visual field analysis of women with migraine. Can J Ophthalmol 2005;40:51-7
   PubMed Web of Science ®Google Scholar
• Avitabile T, Longo A, Caruso S, et al. Changes in visual evoked potentials during the menstrual cycle in young women. Curr Eye Res 2007;32:999-1003
   PubMed Web of Science ®Google Scholar
• Grant AD, Chung SM. The eye in pregnancy: ophthalmologic and neuro-ophthalmologic changes. Clin Obstet Gynecol 2013;56:397-412
   PubMed Web of Science ®Google Scholar
• Errera MH, Kohly RP, da Cruz L. Pregnancy-associated retinal diseases and their management. Surv Ophthalmol 2013;58:127-42
   PubMed Web of Science ®Google Scholar
• Thomas T, Rhodin J, Clark L, Garces A. Progestins initiate adverse events of menopausal estrogen therapy. Climacteric 2003;6:293-301
   PubMed Web of Science ®Google Scholar
• Thomas P, Pang Y, Dong J, et al. Steroid and g protein binding characteristics of the seatrout and human progestin membrane receptor alpha subtypes and their evolutionary origins. Endocrinology 2007;148:705-18
   PubMed Web of Science ®Google Scholar
• Nilsen J, Morales A, Brinton RD. Medroxyprogesterone acetate exacerbates glutamate excitotoxicity. Gynecol Endocrinol 2006;22:355-61
   PubMed Web of Science ®Google Scholar
• Nilsen J, Brinton RD. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 2002;143:205-12
   PubMed Web of Science ®Google Scholar
• Littleton-Kearney MT, Klaus JA, Hurn PD. Effects of combined oral conjugated estrogens and medroxyprogesterone acetate on brain infarction size after experimental stroke in rat. J Cereb Blood Flow Metab 2005;25:421-6
   PubMed Web of Science ®Google Scholar
• Cai W, Zhu Y, Furuya K, et al. Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage. Neuropharmacology 2008;55:127-38
   PubMed Web of Science ®Google Scholar
• Liu A, Margaill I, Zhang S, et al. Progesterone receptors: a key for neuroprotection in experimental stroke. Endocrinology 2012;153:3747-57
   PubMed Web of Science ®Google Scholar
• Wali B, Ishrat T, Won S, et al. Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study. Brain 2014;137:486-502
   PubMed Web of Science ®Google Scholar
• Sar M, Stumpf WE. Neurons of the hypothalamus concentrate (3h)progesterone or its metabolites. Science 1973;182:1266-8
   PubMed Web of Science ®Google Scholar
• Wang JM, Singh C, Liu L, et al. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA 2010;107:6498-503
   PubMed Web of Science ®Google Scholar
• Hussain R, El-Etr M, Gaci O, et al. Progesterone and nestorone facilitate axon remyelination: a role for progesterone receptors. Endocrinology 2011;152:3820-31
   PubMed Web of Science ®Google Scholar
• Li Z, Wang B, Kan Z, et al. Progesterone increases circulating endothelial progenitor cells and induces neural regeneration after traumatic brain injury in aged rats. J Neurotrauma 2012;29:343-53
   PubMed Web of Science ®Google Scholar
• Schumacher M, Mattern C, Ghoumari A, et al. Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors. Prog Neurobiol 2014;113:6-39
   PubMed Web of Science ®Google Scholar